|
NUP188 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.606800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.141400E-01 |
| Normal-vs-Stage2 |
1.831840E-01 |
| Normal-vs-Stage3 |
1.559400E-01 |
| Normal-vs-Stage4 |
8.016400E-01 |
| Stage1-vs-Stage2 |
1.729620E-02 |
| Stage1-vs-Stage3 |
3.802100E-03 |
| Stage1-vs-Stage4 |
2.937200E-01 |
| Stage2-vs-Stage3 |
8.518800E-01 |
| Stage2-vs-Stage4 |
4.261800E-01 |
| Stage3-vs-Stage4 |
4.654800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.291600E-01 |
| Normal-vs-AfricanAmerican |
7.866600E-01 |
| Normal-vs-Asian |
1.695610E-01 |
| Caucasian-vs-AfricanAmerican |
6.589600E-01 |
| Caucasian-vs-Asian |
5.165900E-02 |
| AfricanAmerican-vs-Asian |
1.014370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.985000E-01 |
| Normal-vs-Female |
1.846770E-01 |
| Male-vs-Female |
1.282180E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.165000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.969800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.502400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.414600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.385000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.704000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.407200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.608600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.103600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.258800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.169800E-04 |
| Normal-vs-Grade 2 |
2.631800E-01 |
| Normal-vs-Grade 3 |
1.240820E-01 |
| Normal-vs-Grade 4 |
9.223400E-01 |
| Grade 1-vs-Grade 2 |
6.800900E-03 |
| Grade 1-vs-Grade 3 |
3.77830000000134E-05 |
| Grade 1-vs-Grade 4 |
4.101300E-03 |
| Grade 2-vs-Grade 3 |
8.174200E-04 |
| Grade 2-vs-Grade 4 |
4.518600E-01 |
| Grade 3-vs-Grade 4 |
3.868000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.028050E-01 |
| Normal-vs-ccB subtype |
2.335600E-01 |
| ccA subtype-vs-ccB subtype |
1.897920E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.224600E-01 |
| Normal-vs-N1 |
9.549200E-01 |
| N0-vs-N1 |
8.356600E-01 |
|
|
